Regression of Left Ventricular Hypertrophy in Diabetic Nephropathy: Loss of Parasympathetic Function Predicts Response to Treatment

• Published in: The journal of clinical hypertension (Greenwich, Conn.) Conn.), 2006-05, Vol.8 (5), p.330-335
• Main Authors: Weinrauch, Larry A., Burger, Andrew J., Aronson, Doron, Gleason, Ray E., Lee, Annette T., D'Elia, John A.
• Format: Article
• Language: English
• Subjects: Adult; Aged; Autonomic Nervous System - physiopathology; Diabetes Mellitus, Type 1 - drug therapy; Diabetes Mellitus, Type 1 - physiopathology; Diabetic Nephropathies - drug therapy; Diabetic Nephropathies - physiopathology; Electrocardiography; Female; Glycated Hemoglobin A - analysis; Glycation End Products, Advanced - analysis; Heart Rate; Humans; Hypertrophy, Left Ventricular - physiopathology; Male; Middle Aged; Original Paper; Parasympathetic Nervous System - physiopathology; Prospective Studies
• ISSN: 1524-6175; 1751-7176
• DOI: 10.1111/j.1524-6175.2005.04771.x

Both left ventricular (LV) hypertrophy and decreased autonomic function are predictors of adverse cardiac events. Patients with diabetic nephropathy have an excess cardiovascular risk. The authors determined heart rate variability from 24‐hour ambulatory electrocardiographic recordings and measures of LV mass with systolic and diastolic function from echocardiograms. Patients with diabetic nephropathy (n=16) were seen weekly for insulin and hypertension management. Glycohemoglobin decreased from 9.5±0.4% to 8.3±0.4% (p=0.01), and advanced glycated end products decreased from 12.1 ±2.2 to 7.4±1.2 units (p=0.03). Mean arterial pressure and body weight did not change. Serum creatinine increased (1.8±0.1 mg/dL to 2.0±0.2 mg/dL; p=0.03). The authors used a panel of markers of baseline heart rate variation to assess autonomic function. When covariance of the heart rate interval results were evaluated, the group below the median was found to have a significant decrease in LV mass, from 230 g to 184 g (p=0.013); the group above the median had an increase (182 g to 193 g; p=0.5329). Baseline covariance of the heart rate interval predicted 12‐month changes in LV mass in 13 of 16 patients (predictive accuracy, 81 %). Improvement in measures of heart rate variation correlated with a decrease in LV mass. Parallel improvement of LV mass and autonomic function suggests a common mechanism, allowing for prediction of LV mass improvement through analysis of baseline heart rate variation.